Search

Author/Creator Croisé-Laurent, V.

1. OC-0281 Phase I/II trial of hafnium oxide nanoparticles activated by SBRT in the treatment of liver cancers. (April 2019)

Authors:
Chajon, E.; Pracht, M.; De Baere, T.; N'Guyen, F.; Bronowicki, J.; Vendrely, V.; Baumann, A.; Croisé-Laurent, V.; Rio, E.; Rolland, Y.; Le Sourd, S.; Gustin, P.; Perret, C.; Mornex, F.; Peiffert, D.; Merle, P.; Deutsch, E.
Journal:
Radiotherapy and oncology
Issue:
Volume 133(2019)Supplement 1
Page Start:
S139
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. PH-0159: NANORAY-103: Phase I/II trial of NBTXR3 activated by SBRT in patients with HCC and liver metastases. (November 2020)

Authors:
De Baère, T.; Pracht, M.; Rolland, Y.; Durand-Labrunie, J.; Nguyen, F.; Bronowicki, J.; Vendrely, V.; Cunha, A. Sa; Croisé-Laurent, V.; Rio, E.; Le Sourd, S.; Said, P.; Gustin, P.; Perret, C.; Peiffert, D.; Deutsch, E.; Chajon, E.
Journal:
Radiotherapy and oncology
Issue:
Volume 152(2020)Supplement 1
Page Start:
S74
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search